ea0029oc3.3 | Diabetes Clinical | ICEECE2012
Gu W.
, Hu J.
, Zhu D.
, Tang W.
, Li L.
, Cui W.
, Hong J.
, Zhang Y.
, Wang W.
, Ning G.
Objective: To determine if autologous nonmyeloablative hematopoietic stem cell transplantation (AHSCT) was worthwhile to do in type 1 diabetes adolescents with diabetic ketoacidosis at diagnosis.Research Design and Methods: We enrolled 28 type 1 diabetes patients aged 1430 years in a prospective AHSCT phase II clinical trial. Hematopoietic stem cells were harvested from the peripheral blood following a pretreatment consisting of a combination of cy...